Poster Presentations-29th May, 10:00-14:00

1)      P186 ASSESS OF KNOWLEDGE AND ATTITUDES FROM MILITARY PERSONNEL IN THE PREVENTION OF DRUG ABUSE, By Zeinab Tabanejad

2)      P201 MOLECULAR PREVALENCE OF TRANSFUSION TRANSMITTED VIRUS IN BETA THALASSEMIA CHILDREN, By Abdolreza Sotoodeh

3)      P202 CLINICAL IMPORTANCE OF TT VIRUS INFECTION IN HAEMODIALYSIS PATIENTS, SOUTH OF IRAN, By Abdolreza Sotoodeh

4)      P203 HEPATITIS B VIRUS GENOTYPES IN SOUTH OF IRAN, By Abdolreza Sotoodeh

5)      P206 HOW NURSES WHO ARE OCCUPATIONALLY EXPOSED TO HCV INFECTION CAN HELP TO THE DIFFICULT-TO-TREAT HEPATITIS C POPULATION?, By Nader Aghakhani

6)      P210 STUDY ON THE PRESENCE OF HCV RNA IN THALASSEMIC PATIENTS WITH HEPATITIS C AFTER TREATMENT, By Tahereh Manoochehrabadi

7)      P214 EVALUATION OF GENETIC POLYMORPHISM UPSTREAM AND DOWNSTREAM OF MIR-122 GENE AND THEIR CONTRIBUTION TO CHRONIC HEPATITIS B INFECTION, By Maryam Lotfi

8)      P216 GENOTYPE DISTRIBUTION OF HEPATITIS C AND HEPATITIS B VIRUS IN NORTH OF IRAN, By Maryam Lotfi

9)      P218 THE EFFECTS OF SINGLE NUCLEOTIDE POLYMORPHISM OF IL28B GENE (RS10853728) ON TREATMENT RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN PATIENTS WITH HEPATITIS C IN IRAN, By Mahsa Zamanian

10)  P222 COMPARING ANTI HEPATITIS B ANTIBODY LEVEL IN OBESE WITH NON-OBESE CASES, By Ali Kabir

11)  P224 DEMOGRAPHIC SURVEY OF HDV IN COMPARISON WITH HBV AMONG KHUZESTAN PROVINCE, By Pezhman Alavinejad

12)  P225 VIRAL HEPATITIS: AEROMEDICAL CONCERNS AND WAIVER CONSIDERATIONS ON MILITARY AVIATORS, By Ahmad Ebadi

13)  P226 REAL-LIFE PRACTICE IN THE MANAGEMENT OF CHRONIC HEPATITIS C; A SINGLE-CENTER REPORT FROM THE COMPREHENSIVE HEPATITIS REGISTRY (CHR), ISFAHAN, IRAN, By Behrooz Ataei

14)  P234 MOLECULAR CHARACTERIZATION OF THE TRANSFUSION TRANSMITTED VIRUS (TTV) INFECTION AMONG CHRONIC HBV PATIENTS IN GOLESTAN PROVINCE; IRAN, By Sareh Zhand

15)  P238 HEPATITIS E VIRUS ANTIBODY AND RNA PREVALENCE IN THALASSEMIC PATIENTS WITH HEPATITIS C INFECTION, By Azadeh Dalvand

16)  P240 NATURAL PRODUCTS AND CHRONIC HEPATITIS C VIRUS: SYSTEMATIC REVIEW, By Mohammadreza Noras

17)  P241 EFFECT OF LACTOFERRIN IN PATIENTS WITH CHRONIC HEPATITIS C: SYSTEMATIC REVIEW, By Mohammadreza Noras

18)  P245 MOLECULAR AND SEROLOGICAL DETECTION OF HEPATITS E VIRUS IN THALASSEMIC PATIENTS, By Najmeh Dalvand

19)  P249 INVESTIGATION OF THE ASSOCIATION BETWEEN INTERLEUKIN 17 (RS2397084 AND RS763780) GENE POLYMORPHISMS AND CHRONIC HEPATITIS C VIRUS INFECTION, By Hamideh Tayefi

20)  P251 PREVALENCE OF HAV, HBV AND HCV SEROLOGICAL MARKERS IN LEAN VERSUS OBESE PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE, By Behnam Honarvar

21)  P255 THE CONCEPT OF HEPATITIS IN MEDIEVAL IRANIAN MEDICINE, By Mohammadreza Noras

22)  P256 KNOWLEDGE OF UNIVERSAL PRECAUTIONS TOWARD HBV AND HCV AMONG HEALTH CARE WORKERS AT THE UNIVERSITY TEACHING HOSPITALS IN GUILAN, IRAN, By Farahnaz Joukar

23)  P258 ACCURACY OF FIBROSCAN PERFORMANCE IN EVALUATION OF LIVER FIBROSIS AMONG PATIENTS WITH NASH, By Masoudreza Sohrabi

24)  P262 PROFOUND ANTI-FIBROTIC AND ANTI-PROLIFERATIVE EFFECTS OF SILLIBIN A ON ACTIVATED HUMAN HEPATIC STELLATE CELL, By Seyed Younes Hosseini

25)  P266 STUDY TO DETERMINE THE INCIDENCE OF NEEDLE STICK AND ANTI-HEPATITIS B LEVEL ANTIBODY AND THE ANTIGEN SOURCE OF EXPOSURE IN HEALTH WORKERS ONE OF HOSPITAL AFFILIATED WITH THE UNIVERSITY OF MEDICAL SCIENCES OF URMIA IN 1392, By Mahnaz Mohammadpouri

26)  P271 SURVEY ON FREQUENCY OF D HEPATITIS IN PATIENTS WITH B HEPATITIS REFERRED TO GASTROINTESTINAL AND LIVER DISEASE RESEARCH CENTER IN GUILAN, By Fariborz Mansour-Ghanaei

27)  P272 PUBLIC PREFERENCES FOR ALLOCATION OF DONATED LIVERS FOR TRANSPLANTATION: A CONJOINT ANALYSIS, By Ahmad Danesh

28)  P273 HEPATITIS B SURFACE ANTIGEN (HBSAG) PREVALENCE AMONG URBAN PREGNANT WOMEN VACCINATED AT BIRTH, By Tahmineh Biazar

29)  P275 VIRAL HEPATITIS: THE MOST COMMON INDICATION FOR LIVER TRANSPLANT IN MASHHAD, By Kambiz Akhavan Rezayat

30)  P276 EPIDEMIOLOGY OF VIRAL HEPATITIS IN NORTH OF IRAN; A POPULATION BASED STUDY, By Masoudreza Sohrabi

31)  P279 ANTI-HEPATITIS E ANTIBODY IN HEMODIALYSIS PATIENTS IN ISFAHAN, IRAN: PREVALENCE AND RISK FACTORS, By Behrooz Ataei

32)  P287 SEROPREVALENCE OF HEPATITIS A VIRUS AND HEPATITIS E VIRUS IN KHUZESTAN PROVINCE, SOUTHWEST IRAN: A SYSTEMATIC REVIEW, By Amir Pouremamali

33)  P293 PREVALENCE AND RISK FACTORS OF HEPATITIS C INFECTION IN BIRJAND, By Azadeh Ebrahimzadeh

34)  P297 THE FREQUENCY OF AFP, CA15-3, CA125 AND CA19-9 IN PATIENTS WITH HEPATITIS B AND C, Sara Yeganeh Amirkandeh

35)  P298 DETERMINATION OF HEPATITIS E VIRUS SEROPREVALENCE AMONG BLOOD DONORS IN SOUTH OF IRAN (BUSHEHR), By Gholamreza Khamisipour

36)  P300 Wilson Disease, By Hassan Dastsooz

37)  P301 IDENTIFICATION OF CONSERVED AMINO ACIDS ACROSS WILSON DISEASE GENE: USEFUL APPROACH BEFORE MUTATION DETECTION ANALYSIS, By Hassan Dastsooz

38)  P306 PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN MORBIDLY OBESE PATIENTS UNDERGOING SLEEVE BARIATRIC SURGERY IN IRAN AND ASSOCIATION WITH OTHER COMORBID CONDITIONS, By Shahriar Najafizadeh-Sari

39)  P309 HEMATOLOGIC CHANGES FOLLOWING TREATMENT OF CHRONIC HCV INFECTION WITH INTERFERON BASED REGIMEN: A COMMON BUT SAFE SIDE EFFECT, By Zahra Ahmadinejad

40)  P310 THE CORRELATION BETWEEN NON-ALCOHOLIC FATTY LIVER DISEASE AND CORONARY ARTERY DISEASE IN PATIENTS UNDERGONE CORONARY ANGIOGRAPHY IN IRAN, By Hamidreza Karimi-sari

41)  P311 A RANDOMIZED CONTROLLED TRIAL OF TWO SCHEDULES OF HEPATITIS B VACCINATION IN PREDIALYSED CHRONIC RENAL FAILURE PATIENTS, By Zahra Khazaeipour